Syncom Formulations (India) Ltd
₹14.11
(0.28%)
Mon, 25 May 2026, 03:52 pm
Health Technology
Pharmaceuticals: Major
24.5KSyncom Formulations (India) Share Price Live Chart
1 Day
(0.28%)
No Result Found
Summary
Market Cap
1347.02
Net Profit
49.43
P/B
4.52
Sector P/E
34.11
P/E
31.04
EV/EBITDA
21.60
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.05
RONW (Industry)
13.18
ROE
15.68
ROCE
18.54
Debt/Equity
0.12
EPS (TTM)
0.73
Dividend Yield
0
Book Value
4.03
Interest Cover
63.39
Analysis
all
- Syncom Formulations (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Syncom Formulations (India) is profitable, therefore cash runway is not a concern.
- Syncom Formulations (India) is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (98.3%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 9.3x debt.
- Unable to calculate sustainability of dividends as Syncom Formulations (India) has not reported any payouts.
- Unable to evaluate Syncom Formulations (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Syncom Formulations (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
- The level of debt compared to net worth has increased over the past 5 years (5.5% vs 6.3% today).
- High level of physical assets or inventory.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 |
| FII | 0.21 | 0.26 | 0.10 | 0.41 | 0.11 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 49.21 | 49.17 | 49.33 | 49.02 | 49.32 |
| Government | 0.00 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 20.80 | 16.84 | 15.29 | 12.88 | 11.33 | 8.92 | 4.96 |
| Fibonacci | 16.84 | 15.33 | 14.39 | 12.88 | 11.37 | 10.43 | 8.92 |
| Camarilla | 14.83 | 14.47 | 14.10 | 12.88 | 13.38 | 13.01 | 12.65 |
Pivots Level: Classic
R3
+7.92
20.80
R2
+3.96
16.84
R1
+2.41
15.29
S1
-1.55
11.33
S2
-3.96
8.92
S3
-7.92
4.96
Moving Average
Period
Value
10-EMA
14.43
20-EMA
14.13
30-EMA
13.89
50-EMA
13.63
100-EMA
13.75
200-EMA
14.63
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 22 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 12 Feb 2026 | board-meetings | Quarterly Results | |
| 11 Aug 2025 | agm | ||
| 19 Sept 2024 | agm | ||
| 23 Aug 2024 | agm | Annual General Meeting | 24 Sept 2024 |
| 18 Aug 2023 | agm | Annual General Meeting | 20 Sept 2023 |
| 14 Aug 2023 | agm | ||
| 13 Aug 2022 | dividend | ₹0.03 Dividend /Share | 13 Sept 2022 |
| 13 Aug 2022 | agm | ||
| 27 Aug 2021 | agm |
Peer Comparison
Syncom Formulations (India) Ltd
Cipla Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Syncom Formulations (India) Ltd About
Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1988
Headquarters
CEO
ANKIT KEDARMAL BANKDA
Employees
Contact
Website
http://www.syncomformulations.com
finance@sfil.in; sfil87@syncomformulations.com
Phone
91-22-30887744
Location
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093
Syncom Formulations (India) Ltd Company History
| Year | History |
|---|---|
| 2011 |
|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2022 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| HRTI PRIVATE LIMITED | bulk | Sell | 8150466 | 25.14 | 09 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 8536197 | 25.26 | 09 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 7106640 | 24.91 | 09 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 7106640 | 24.86 | 09 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 4707047 | 23.37 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 5329278 | 23.42 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 5329278 | 23.46 | 06 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Sell | 5094857 | 23.4 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 5331418 | 20.79 | 26 Aug 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 7590091 | 20.78 | 26 Aug 2024 |